APODAN A/S: Financial statements 2013
CVR: 14123849
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
APODAN A/S (CVR 14123849) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 4,752,958 and a net result of DKK 181,857 compared with DKK 546,930 the year before. That is an increase of 70.8% compared with the year before. Equity in the 2013 report amounted to DKK 4,350,111. The solvency ratio was 51.7%.
- Gross Profit
- DKK 4,752,958
- Profit/Loss
- DKK 181,857
- Equity
- DKK 4,350,111
- Total Assets
- DKK 8,415,023
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | 4.8 mio. | 182 t. | 4.4 mio. | - |
| 2012 | - | 2.8 mio. | 547 t. | 3 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
APODAN A/S has published its annual report for 2012. Gross profit came to DKK 2,783,051, and the net result was DKK 546,930.
About APODAN A/S
APODAN A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 1990. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named APODANNORDIC HEALTHCARE A/S and ROTAVELET A/S. The management consists of Morten Lodberg Petersen. The board consists of Andreas Peter Illum Wildfang von Scholten (chair), Jacob Marcus Emanuel Drakenberg Walberg and Morten Lodberg Petersen. The company is owned by Sanviva Denmark ApS. The company has 15 employees (2026). In 2025, the company reported a gross profit of DKK 14,962,819 and a net result of DKK 3,554,949 compared with DKK 2,573,254 the year before. Equity in the 2025 report amounted to DKK 11,617,033.